New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.
Related Articles
HealthV.A. Institutes New Consent Requirements for Some Psychiatric Drugs
Veterans under 30 will have to sign forms before being given antidepressants. Medical groups fear the moves may stigmatize mental health treatment.
HealthBattle of Hospital A.I. vs. Insurer A.I. Is Pushing Medical Costs Higher
The use of artificial intelligence by hospitals and health insurers is escalating their longstanding feud over paying for medical care.


